08 - Code Blue: Resuscitating Antimicrobial Stewardship and Healthcare Epidemiology Post-COVID

Thursday, September 30, 2021

11:00 AM - 12:15 PM EDT

Moderator(s)

Christopher Ohl, MD

Professor of Medicine
Infectious Diseases
Wake Forest Baptist Health System
Winston Salem, NC, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.
Louise Dembry, MD, MS, MBA

Professor of Medicine/Infectious Diseases
Yale University
New Haven, CT, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Speaker(s)

Catherine Passaretti, MD

Medical Director Infection Prevention/Associate Professor
Atrium Health
Charlotte, NC, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.
TC

Teena Chopra, MD, MPH

Corporate Medical Director of Infection Prevention and Hospital Epidemiology
Detroit Medical Center, Wayne State University
Detroit, MI, United States

Abbvie (Individual(s) Involved: Self): Speakers' bureau; Ferring (Individual(s) Involved: Self): Consultant; Pfizer (Individual(s) Involved: Self): Consultant; Shionogi (Individual(s) Involved: Self): Consultant
Arjun Srinivasan, MD

Associate Director for Healthcare Associated Infection Prevention Programs, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention
Atlanta, GA, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Participants should be aware of the following financial/non-financial relationships:

Christopher Ohl, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Louise M. Dembry, MD, MS, MBA: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Catherine Passaretti, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Teena Chopra, MD, MPH: Abbvie (Individual(s) Involved: Self): Speakers' bureau; Ferring (Individual(s) Involved: Self): Consultant; Pfizer (Individual(s) Involved: Self): Consultant; Shionogi (Individual(s) Involved: Self): Consultant

Arjun Srinivasan, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
ACPE Credits: ACPE 1.25 Knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-21-001-H01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

select and prioritize infection prevention and antibiotic stewardship programs/ interventions to implement or re-implement as we recover from the COVID-19 pandemic
identify lessons learned during the COVID-19 pandemic that can add to or advance existing infection prevention and antibiotic stewardship programs at an acute care health care facility
identify barriers to moving forward in infection prevention and antibiotic stewardship as we recover from the COVID-19 pandemic and strategies to address them

Presentations:

Impact of COVID on Infection Prevention
Speaker: Catherine Passaretti, MD – Atrium Health
Impact of COVID-19 on Antibiotic Use and Antimicrobial Resistance
Speaker: Teena Chopra, MD, MPH – Detroit Medical Center, Wayne State University
Moving Forward and Back to “Normal”
Speaker: Arjun Srinivasan, MD – Centers for Disease Control and Prevention